Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

BVS stock hub

Bioventus Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

877.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BVS

In the news

Latest news · BVS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.1

P25 12.3P50 18.4P75 33.1

Trailing P/E26

P25 14.9P50 23.2P75 38.5

ROE16.5

P25 -105.6P50 -46.5P75 -3.1

ROIC12.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

241

Groups with data

Currency

USD

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001665988
Company name	Bioventus Inc.
Country	United States
Country code	US
Cusip	09075A108
Employees	940
Employees Change	10%
Employees Change Percent	1.08
Enterprise value	$1.1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2021-02-11
Isin	US09075A1088
Last refreshed	2026-05-10
Market cap	$877.1M
Market cap category	Small-Cap
Price	$10.5
Price currency	USD
Rev Per Employee	613,085.11x
Sector	Healthcare
Sic	3841
Symbol	BVS
Website	https://www.bioventus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.25%
EV Earnings	39.66x
EV Sales Forward	1.82x
EV/EBIT	18.75x
EV/EBITDA	13.96x
EV/FCF	11.23x
EV/Sales	1.96x
FCF yield	11.47%
Forward P/E	13.08x
P/B ratio	3.76x
P/E ratio	26.05x
P/S ratio	1.52x
PEG ratio	1.25x
PS Forward	1.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.46%
EBITDA Margin	14.04%
FCF margin	17.46%
Gross margin	68.69%
Gross Profit	$395.9M
Gross Profit Growth	3.39%
Gross Profit Growth Q	9.29%
Gross Profit Growth3 Y	6.33%
Gross Profit Growth5 Y	10.91%
Net Income	$28.5M
Net Income Growth Quarters	7%
Net Income Growth Years	3%
Net Income Growth5 Y	45.11%
Pretax Margin	5.84%
Profit Margin	4.94%
Profit Per Employee	$30,300
Profitable Years	1
ROA	5.61
Roa5y	1.59
ROCE	11.99
ROE	16.46
Roe5y	-15.09
ROIC	12.36
Roic5y	3.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	59.38%
Cagr3y	120.53%
Cagr5y	-6.45%
EPS Growth Quarters	1
EPS Growth Years	3
EPS Growth5 Y	30.17
FCF Growth	320.55%
FCF Growth5 Y	26.63%
OCF Growth	304.17%
OCF Growth3 Y	117.74%
OCF Growth5 Y	23.34%
Revenue Growth	1.52x
Revenue Growth Q	6.63x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	3.89x
Revenue Growth5 Y	12.19x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.86
Assets	$650.5M
Cash	$35.8M
Current Assets	$249.8M
Current Liabilities	$148.1M
Debt	$288.4M
Debt EBITDA	$3.34
Debt Equity	$1.23
Debt FCF	$2.87
Equity	$234.3M
Interest Coverage	2.59
Liabilities	$416.3M
Long Term Assets	$400.7M
Long Term Liabilities	$268.2M
Net Cash	$-252.6M
Net Cash By Market Cap	$-28.8
Net Debt EBITDA	$3.12
Net Debt Equity	$1.08
Net Debt FCF	$2.51
Tangible Book Value	$-178.2M
Tangible Book Value Per Share	$-2.63
WACC	7.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.69
Inventory Turnover	2.04
Net Working Capital	$88.8M
Quick ratio	1.06
Working Capital	$101.7M
Working Capital Turnover	$6.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.22%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	59.33%
200-day SMA	7.87
3Y total return	973.07%
50-day SMA	9.4
50-day SMA vs 200-day SMA	50over200
5Y total return	-28.33%
All Time High	19.94
All Time High Change	-47.34%
All Time High Date	2021-06-28
All Time Low	0.8
All Time Low Change	1,212.66%
All Time Low Date	2023-03-31
ATR	0.52
Beta	0.72
Beta1y	1.13
Beta2y	0.89
Ch YTD	41.13
High	10.93
High52	11.25
High52 Date	2026-05-07
High52ch	-6.66%
Low	10.33
Low52	5.81
Low52 Date	2025-08-05
Low52ch	80.72%
Ma50ch	11.7%
Price vs 200-day SMA	33.47%
RSI	59.88
RSI Monthly	61.13
RSI Weekly	71.06
Sharpe ratio	1.12x
Sortino ratio	2.07
Total Return	-7.22%
Tr YTD	41.13
Tr1m	18.78%
Tr1w	3.86%
Tr3m	23.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$0.07
Earnings EPS Estimate Growth	-12.5
Earnings Revenue Estimate	129,753,680x
Earnings Revenue Estimate Growth	4.74x
Operating Income	$60.3M
Operating Income Growth	65.65
Operating Income Growth Q	78.75
Operating Income Growth5 Y	14.36
Operating margin	10.46
Price target	$14
Price Target Change	$33.33

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33,710,995%
Float Percent	40.36%
Net Borrowing	-9,145,000
Shares Insiders	2.66%
Shares Institutions	38.97%
Shares Out	83,534,785
Shares Qo Q	1.08%
Shares Yo Y	7.22%
Short Float	4%
Short Ratio	2.78
Short Shares	1.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$87.1M
Average Volume	508,229.25x
Bv Per Share	2.79
CAPEX	$-2.3M
Ch1m	18.78
Ch1w	3.86
Ch1y	59.33
Ch3m	23.38
Ch3y	973.1
Ch5y	-28.33
Ch6m	40.94
Change	-1.41%
Change From Open	-3.93
Close	10.65
Days Gap	2.63
Depreciation Amortization	20,639,000
Dollar Volume	3,785,670
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$60.3M
EBITDA	$80.9M
EPS	$0.4
F Score	8
FCF	$100.6M
FCF EV Yield	8.91x
FCF Per Share	$1.2
Financing CF	-86,231,000
Fiscal Year End	December
Founded	2,011
Goodwill	7,462,000
Graham Number	5.03287
Graham Upside	-52.07
Income Tax	$-899,000
Investing CF	-2,996,000
Ipr	-19.23
Iprfo	-30.46
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-28
Last Split Type	Never
Last10k Filing Date	2026-03-05
Lynch Fair Value	$10.08
Lynch Upside	-4.02
Ma150	8.16
Ma150ch	28.64%
Ma20	10.14
Ma20ch	3.52%
Net CF	13,044,000
Next Earnings Date	2026-08-05
Open	10.93
Optionable	Yes
P FCF Ratio	8.72
P OCF Ratio	8.52
Position In Range	28.33
Post Close	10.5
Postmarket Change Percent	-0.39
Postmarket Price	$10.46
Ppne	25,981,000
Price Date	2026-05-08
Price EBITDA	$10.84
Relative Volume	0.71x
Revenue	576,300,000x
SBC By Revenue	2.35x
Share Based Comp	13,523,000
Tax By Revenue	-0.16x
Tr6m	40.94%
Us State	North Carolina
Volume	360,540
Z Score	1.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BVS pay a dividend?

Capital-return profile for this ticker.

Performance

BVS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+39.0%

Float: +40.4% of shares outstanding

Insider ownership

+2.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.9

Neutral momentum band

Price vs 200-day MA

+33.5%

50/200-day relationship not available

Beta (5Y)

0.72

Less volatile than the market

Sharpe ratio

1.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BVS stock rating?

Bioventus Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BVS analysis?

The full report lives at /stocks/BVS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BVS?

The latest report frames BVS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BVS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.